Asian Pac J Cancer Prev. 2017 Mar 01;18(3):681-685. doi: 10.22034/APJCP.2017.18.3.681.

Follicular lymphoma: an Institutional Analysis.

Asian Pacific journal of cancer prevention : APJCP

Ajay Gogia, Vinod Raina, Lalit Kumar, Atul Sharma, Mehar Chand Sharma, Saumya Ranjan Mallick

PMID: 28440975 PMCID: PMC5464484 DOI: 10.22034/APJCP.2017.18.3.681

Abstract

Background: Follicular lymphoma (FL) is second most common lymphoma in adult, constituted 20% of all lymphoma cases in the west. There is limited information is available on FL from India. Methods: The clinico-pathological profile, treatment outcome and prognostic factors for survival were assessed retrospectively in 181 patients of FL seen at our center over a period of 17 years ( 1996-2012). Results: There were 120 males and 61 females. The median age was 51 years (24-80 years). The common presenting features were lymphadenopathy 71%, fatigue 23% and fever 20%. Ann Arbor stage distribution was: stage I - 9%, stage II - 11%, stage III -22 % and stage IV - 58%. Extra nodal involvement and bulky disease were present in 22% and 19% patients respectively. Follicular Lymphoma International Prognostic Index (FLIPI) 1 score : Low -25%, Intermediate-45% and high risk in 30% of cases. One forty five patients (80%) received treatment at presentation or during follow-up. Chemotherapeutic regimen used were: CHOP-45 , CVP-51, chlorambucil and prednisolone -7 , BR ( bendamustine and rituximab)-12, RCHOP- 14 RCVP – 7 and other regimen were used in 5 cases. The overall response (ORR) and complete remission (CR) rates were 70% and 35% respectively. Median overall survival (OS) and event free survival (EFS) was 5.5 years and 2.5 years respectively, with median follow up period of 3.0 years. Grade 3 histology, failure to attain CR, low serum albumin, and high risk FLIPI were significantly associated with lower event free survival. High risk FLIPI (HR 1.46, 95% CI 1.03-2.10, p=0.003) and failure to attain CR (HR 2.64, CI 1.10-4.30, p=0.001) were predictors of poor OS. Conclusions: FL represents 9 % of all lymphoma in adult. This is the largest data from single institute from India. Eighty percentage of patients presented in stage III/IV disease. High risk FLIPI and failure to attain CR were important prognostic variables for OS.

Creative Commons Attribution License

Keywords: Follicular lymphoma; outcome; India

References

1. Leuk Lymphoma. 2012 Oct;53(10):1961-5 - PubMed
2. J Clin Oncol. 2007 Feb 10;25(5):579-86 - PubMed
3. Asian Pac J Cancer Prev. 2010;11(1):73-7 - PubMed
4. Cancer. 1972 Jul;30(1):31-8 - PubMed
5. Expert Rev Anticancer Ther. 2015;15(11):1337-49 - PubMed
6. J Clin Oncol. 2008 Oct 1;26(28):4579-86 - PubMed
7. J Clin Oncol. 2009 Apr 1;27(10):1607-14 - PubMed
8. Ann Oncol. 2008 Mar;19(3):553-9 - PubMed
9. J Natl Cancer Inst. 2011 Dec 7;103(23):1799-806 - PubMed
10. Blood. 2005 Dec 1;106(12):3725-32 - PubMed
11. J Clin Oncol. 2007 May 20;25(15):1986-92 - PubMed
12. Blood. 2008 Dec 15;112(13):4824-31 - PubMed
13. N Engl J Med. 1984 Dec 6;311(23):1471-5 - PubMed
14. Lancet. 2013 Apr 6;381(9873):1203-10 - PubMed
15. Lancet. 2011 Jan 1;377(9759):42-51 - PubMed

Publication Types

• Journal Article